Record Full Year 2023 Net Sales Increase 19.6% Year-Over-Year to Over $1.1 Billion Adjusted EBITDA Exceeds Company's Full Year 2023 Guidance Reports Highest Annual Cash from Operations in the Company's History of $61.9 Million Provides First …
PEMBROKE, Bermuda, Feb. 28, 2024 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) today reported the following results for the fourth quarter 2023 as compared to the same period in …
FY 2023 Third Party Net Sales from Continuing Operations of $457.2 million FY 2023 Third Party Net Sales from Discontinued Operations of $409.2 million Updated Reporting Framework: Continuing Operations consists of the Dental Business and the majority of …
New Bitcoin Layer-Two Network Designed To Expand Bitcoin’s Functionality, Spark Innovation, and Encourage Adoption Fort Lauderdale, FL, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Marathon Digital Holdings, Inc. (NASDAQ:MARA) ("Marathon" or "Company…
One-third of hospital acquired sepsis is related to central-lines, PICCs, and mid-lines SANTA BARBARA , CALIFORNIA , UNITED STATES , February 28, 2024 /EINPresswire.com/ -- “Clearly, children with cancer are at disproportional risk of line …
WASHINGTON, D.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spencer Fane LLP is pleased to announce the firm has established a presence in the Washington, D.C. market with the addition of three partners who specialize in high-stakes patent litigation and trade …
Homepage > Podcast > My Career in Data Season 2 Episode 8: Mathias Vercauteren, President and Principal, Data Vantage Consulting By Natalie Raymond on February 28, 2024February 27, 2024 Welcome back to season two of My Career in Data – a DATAVERSITY …
HOPKINTON, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest single-family home community in prestigious Hopkinton, Massachusetts will be opening for sale in …
Recruiting for Good helps companies find professionals to fund Girl Causes. The staffing agency is rewarding referrals with sweet Vegas Dining rewards. SANTA MONICA, CALIFORNIA, UNITED STATES, February 28, 2024 /EINPresswire.com/ -- Recruiting …
Continued Collaboration to Advocate for and Elevate Conversation on Weight Health Ms. Winfrey to Donate Financial Interest in WeightWatchers to the National Museum of African American History and Culture NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- WW …
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer …
PITTSBURGH, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ: DUOL), the world’s leading mobile learning platform, announced results for the fourth quarter and full year ended December 31, 2023 in a shareholder letter that is posted at investors. …
CHICAGO and VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, …
Amtagvi™ (lifileucel) U.S. Launch Fully Underway Following U.S. Food and Drug Administration (FDA) Approval as the First and Only One-Time, Individualized T cell Therapy for a Solid Tumor Cancer Amtagvi Regulatory Submissions on Track in the European Union …
Fourth Quarter 2023 End of Period Subscribers of 3.8 million, including 67 thousand End of Period Clinical Subscribers Revenues of $206.0 million Gross margin of 60.6%; excluding the net impact of restructuring charges, adjusted gross margin of 61.4% …
LEXINGTON, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of …
BURLINGTON, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient …
- Company had approximately $431 million in pro-forma cash as of December 31, 2023, adjusted for $100 million consideration from Novartis agreements and $100 million public offering - - Strong cash position and anticipated milestones/reimbursements provide …
WALTHAM, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René …
Achieved FY2023 core financial objectives, delivering substantial ongoing reductions in expenses and cash burn while expanding revenue and gross margins Completed merger with SomaLogic, activating strategy to build scaled leader in life sciences tools and …
05 days 01:48:18
